about
Computational properties of mitochondria in T cell activation and fateBortezomib sensitizes human renal cell carcinomas to TRAIL apoptosis through increased activation of caspase-8 in the death-inducing signaling complex.Adaptive control of innate immunity.Resuscitating cancer immunosurveillance: selective stimulation of DLL1-Notch signaling in T cells rescues T-cell function and inhibits tumor growth.NK cells: immune cross-talk and therapeutic implications.Is thymus redundant after adulthood?Challenges and future perspectives of T cell immunotherapy in cancerTNF-related apoptosis-inducing ligand as a therapeutic agent in autoimmunity and cancer.Cooperativity of adaptive and innate immunity: implications for cancer therapy.Common gamma chain cytokines in combinatorial immune strategies against cancerMolecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients.Antigen presented by tumors in vivo determines the nature of CD8+ T-cell cytotoxicity.Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibodyAntitumor effect of some 3d-metal complexes of N-isonicotinoyl-N'-o-hydroxythiobenzhydrazide.Innate-Adaptive Immune Crosstalk 2016Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor T cell immunityAscitic growth of a spontaneous transplantable T cell lymphoma induces thymic involution. 2. Induction of apoptosis in thymocytesImpairment of T-cell functions with the progressive ascitic growth of a transplantable T-cell lymphoma of spontaneous originMechanism of thymocyte apoptosis induced by serum of tumor-bearing host: the molecular events involved and their inhibition by thymosin alpha-1Ascitic growth of a spontaneous transplantable T cell lymphoma induces thymic involution. 1. Alterations in the CD4/CD8 distribution in thymocytesCooperative action of CD8 T lymphocytes and natural killer cells controls tumour growth under conditions of restricted T-cell receptor diversityUpdate on the current revolution in cancer immunotherapyCD8+ T Lymphocyte and NK Cell Network: Circuitry in the Cytotoxic Domain of Immunity
P50
Q28070307-600D0F2B-7631-4F29-AACC-4589E7E36820Q33862527-54F62D76-9696-4F0B-BCDF-8207C2091766Q33912853-80116F1B-A857-434A-A636-A09C37B87DCFQ35256189-AB78FAF8-8D4F-4206-A61F-2EFF5365BF40Q35591444-0CA088ED-35FD-45A6-BF87-E05CFABBE341Q35690465-F7CC22AE-8230-48CF-ACAF-BB96E83DC7A9Q35843507-FFAF2045-6417-454A-914F-992B38B75A6DQ36365504-E91CA416-C90C-408F-B9E5-758B513C96E8Q36429508-03D77397-0E1C-4293-9CE1-C7C0B4849117Q36455872-8673A7F1-2F93-430D-B01A-8563733091FEQ36960012-0101E642-B613-468E-897B-0D1DC031BF16Q37306957-BBFCA5FA-9EE4-4D40-A151-7D9ADFE785AAQ37367298-3D7A6B14-54D1-4D30-B66D-1037B4CF089CQ42105787-034E286C-A5CD-4382-855F-DC8BC397A5DAQ42358511-26FA3F80-3DB4-4C1C-BD75-713C04B8F0F0Q64085682-34EE737D-B73F-4FF4-A1E5-390A9F7D64B6Q73007496-A142124E-E560-4333-9CF6-E06C67CBE9E1Q73466633-6981A41F-74A1-4F6E-8258-8B194C918D47Q73480207-D161F206-A893-4175-8E9D-44A508F25AF7Q74164678-6F9BD86F-A8A0-4B93-9F68-241E1326EB40Q82401925-F09A2CF1-DE9E-4B74-A191-FD2CE28E070CQ91287304-7FC18397-8929-4EE1-84B8-ACCF0158022DQ92921995-8101B023-C877-4A39-8ECA-E021CE8992E1
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anil Shanker
@ast
Anil Shanker
@en
Anil Shanker
@es
Anil Shanker
@nl
type
label
Anil Shanker
@ast
Anil Shanker
@en
Anil Shanker
@es
Anil Shanker
@nl
prefLabel
Anil Shanker
@ast
Anil Shanker
@en
Anil Shanker
@es
Anil Shanker
@nl
P106
P1153
7005388954
P21
P31
P496
0000-0001-6372-3669